Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility

eLife

Volumn 2014, Issue 3, 2014, Pages

  Cipolat, Sara ^a,b   Hoste, Esther ^a,b   Natsuga, Ken ^b,c   Quist, Sven R ^b,d   Watt, Fiona M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^c HOKKAIDO UNIVERSITY   (Japan)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7, 12 DIMETHYLBENZ [A] ANTHRACENE; AROMATIC HYDROCARBON RECEPTOR; BROXURIDINE; CHAPERONIN 60; DEXAMETHASONE; ENVOPLAKIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 6; INVOLUCRIN; NATURAL KILLER CELL RECEPTOR NKG2D; PERIPLAKIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P53; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CYTOKINE; KLRK1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PLAKIN; PPL PROTEIN, MOUSE; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BENIGN TUMOR; CANCER SUSCEPTIBILITY; CD4+ T LYMPHOCYTE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CUTANEOUS PARAMETERS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETER; GENE MUTATION; HRAS GENE; HYPERKERATOSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PARAKERATOSIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BARRIER; SKIN CANCER; SQUAMOUS CELL CARCINOMA; VIRUS ONCOGENE; 129 MOUSE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; EPIDERMIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NUDE MOUSE; PATHOLOGY; PERMEABILITY; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TIME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EPIDERMIS; KERATINOCYTES; MEMBRANE PROTEINS; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PAPILLOMA; PERMEABILITY; PLAKINS; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 84899867231     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.01888     Document Type: Article

References (64)

1. Abel EL, Angel JM, Kiguchi K, DiGiovanni J. 2009. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nature Protocols 4:1350-1362. doi: 10.1038/nprot.2009.120.
2. Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schroder JM, Feingold KR, Elias PM. 2008. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. The Journal of Investigative Dermatology 128:917-925. doi: 10.1038/sj.jid.5701099.
3. Aho S, Li K, Ryoo Y, McGee C, Ishida-Yamamoto A, Uitto J, Klement JF. 2004. Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development. Molecular and Cellular Biology 24:6410-6418. doi: 10.1128/MCB.24.14.6410-6418.2004.
4. Al-Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ. 2005. A role for TSLP in the development of inflammation in an asthma model. The Journal of Experimental Medicine 202:829-839. doi: 10.1084/jem.20050199.
5. Antsiferova M, Huber M, Meyer M, Piwko-Czuchra A, Ramadan T, MacLeod AS, Havran WL, Dummer R, Hohl D, Werner S. 2011. Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nature Communications 2:576. doi: 10.1038/ncomms1585.
6. Arana A, Wentworth CE, Fernandez-Vidaurre C, Schlienger RG, Conde E, Arellano FM. 2010. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. The British Journal of Dermatology 163:1036-1043. doi: 10.1111/j.1365-2133.2010.09887.x.
7. Bieber T. 2010. Atopic dermatitis. Annals of Dermatology 22:125-137. doi: 10.5021/ad.2010.22.2.125.
8. Brown SJ, McLean WH. 2012. One remarkable molecule: filaggrin. The Journal of Investigative Dermatology 132:751-762. doi: 10.1038/jid.2011.393.
9. Candi E, Schmidt R, Melino G. 2005. The cornified envelope: a model of cell death in the skin. Nature Reviews Molecular Cell Biology 6:328-340. doi: 10.1038/nrm1619.
10. Demehri S, Liu Z, Lee J, Lin MH, Crosby SD, Roberts CJ, Grigsby PW, Miner JH, Farr AG, Kopan R. 2008. Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLOS Biology 6:e123. doi: 10.1371/journal.pbio.0060123.
11. Demehri S, Turkoz A, Manivasagam S, Yockey LJ, Turkoz M, Kopan R. 2012. Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin. Cancer Cell 22:494-505. doi: 10.1016/j.ccr.2012.08.017.
12. De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C, Protti MP. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. The Journal of Experimental Medicine 208:469-478.
13. Di Piazza M, Nowell CS, Koch U, Durham AD, Radtke F. 2012. Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting. Cancer Cell 22:479-493. doi: 10.1016/j.ccr.2012.08.016.
14. Djian P, Easley K, Green H. 2000. Targeted ablation of the murine involucrin gene. The Journal of Cell Biology 151:381-388. doi: 10.1083/jcb.151.2.381.
15. Dumortier A, Durham AD, Di Piazza M, Vauclair S, Koch U, Ferrand G, Ferrero I, Demehri S, Song LL, Farr AG, Leonard WJ, Kopan R, Miele L, Hohl D, Finke D, Radtke F. 2010. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLOS ONE 5:e9258. doi: 10.1371/journal.pone.0009258.
16. Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, Callanan JJ, Kawasaki H, Shiohama A, Kubo A, Sundberg JP, Presland RB, Fleckman P, Shimizu N, Kudoh J, Irvine AD, Amagai M, McLean WH. 2009. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nature Genetics 41:602-608. doi: 10.1038/ng.358.
17. Gao J, Lauer FT, Dunaway S, Burchiel SW. 2005. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicological Sciences: an Official Journal of the Society of Toxicology 86:68-74. doi: 10.1093/toxsci/kfi176.
18. Gasser S, Orsulic S, Brown EJ, Raulet DH. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436:1186-1190. doi: 10.1038/nature03884.
19. Guinea-Viniegra J, Zenz R, Scheuch H, Jimenez M, Bakiri L, Petzelbauer P, Wagner EF. 2012. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. The Journal of Clinical Investigation 122:2898-2910. doi: 10.1172/JCI63103.
20. Hayday AC. 2009. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 31:184-196. doi: 10.1016/j.immuni.2009.08.006.
21. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH. 1993. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14:2353-2358. doi: 10.1093/carcin/14.11.2353.
22. Hirst GL, Balmain A. 2004. Forty years of cancer modelling in the mouse. European Journal of Cancer: official Journal for European Organization for Research and Treatment of Cancer (eortc) [and] European Association for Cancer Research (eacr) 40:1974-1980. doi: 10.1016/j.ejca.2004.05.013.
23. Huston DP, Liu YJ. 2006. Thymic stromal lymphopoietin:a potential therapeutic target for allergy and asthma. Current Allergy and Asthma Reports 6:372-376. doi: 10.1007/s11882-996-0006-7.
24. Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. 2012. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. International Journal of Cancer Journal International Du Cancer 130:1160-1167. doi: 10.1002/ijc.26105.
25. Jensen AO, Svaerke C, Kormendine Farkas D, Olesen AB, Kragballe K, Sorensen HT. 2012. Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006). American Journal of Clinical Dermatology 13:29-36. doi: 10.2165/11593280-000000000-00000.
26. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodriguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H. 2008. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63:1255-1266. doi: 10.1111/j.1398-9995.2008.01768.x.
27. Johansson M, Denardo DG, Coussens LM. 2008. Polarized immune responses differentially regulate cancer development. Immunological Reviews 222:145-154. doi: 10.1111/j.1600-065X.2008.00600.x.
28. Kaae J, Thyssen JP, Johansen JD, Meldgaard M, Linneberg A, Allen M, Skov L. 2013. Filaggrin gene mutations and risk of basal cell carcinoma. The British Journal of Dermatology 169:1162-1164. doi: 10.1111/bjd.12573.
29. King DP, Hyde DM, Jackson KA, Novosad DM, Ellis TN, Putney L, Stovall MY, Van Winkle LS, Beaman BL, Ferrick DA. 1999. Cutting edge: protective response to pulmonary injury requires gamma delta T lymphocytes. The Journal of Immunology: official Journal of the American Association of Immunologists 162:5033-5036.
30. Kuramoto N, Takizawa T, Matsuki M, Morioka H, Robinson JM, Yamanishi K. 2002. Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. The Journal of Clinical Investigation 109:243-250. doi: 10.1172/JCI13563.
31. Leonard WJ. 2002. TSLP: finally in the limelight. Nature Immunology 3:605-607. doi: 10.1038/ni0702-605.
32. Liu YJ. 2006. Thymic stromal lymphopoietin: master switch for allergic inflammation. The Journal of Experimental Medicine 203:269-273. doi: 10.1084/jem.20051745.
33. Lopez-Pajares V, Yan K, Zarnegar BJ, Jameson KL, Khavari PA. 2013. Genetic pathways in disorders of epidermal differentiation. Trends in Genetics: TIG 29:31-40. doi: 10.1016/j.tig.2012.10.005.
34. Maatta A, DiColandrea T, Groot K, Watt FM. 2001. Gene targeting of envoplakin, a cytoskeletal linker protein and precursor of the epidermal cornified envelope. Molecular and Cellular Biology 21:7047-7053. doi: 10.1128/MCB.21.20.7047-7053.2001.
35. Milstone LM. 2004. Epidermal desquamation. Journal of Dermatological Science 36:131-140. doi: 10.1016/j.jdermsci.2004.05.004.
36. Modi BG, Neustadter J, Binda E, Lewis J, Filler RB, Roberts SJ, Kwong BY, Reddy S, Overton JD, Galan A, Tigelaar R, Cai L, Fu P, Shlomchik M, Kaplan DH, Hayday A, Girardi M. 2012. Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 335:104-108. doi: 10.1126/science.1211600.
37. Moore TA, Moore BB, Newstead MW, Standiford TJ. 2000. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. The Journal of Immunology: official Journal of the American Association of Immunologists 165:2643-2650.
38. Niemann C, Owens DM, Schettina P, Watt FM. 2007. Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type. Cancer Research 67:2916-2921. doi: 10.1158/0008-5472.CAN-06-3427.
39. Owens DM, Watt FM. 2001. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Research 61:5248-5254.
40. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 38:441-446. doi: 10.1038/ng1767.
41. Palmer CN, Ismail T, Lee SP, Terron-Kwiatkowski A, Zhao Y, Liao H, Smith FJ, McLean WH, Mukhopadhyay S. 2007. Filaggrin null mutations are associated with increased asthma severity in children and young adults. The Journal of Allergy and Clinical Immunology 120:64-68. doi: 10.1016/j.jaci.2007.04.001.
42. Pavlidis P, Noble WS. 2003. Matrix2png: a utility for visualizing matrix data. Bioinformatics [bioinformatics (oxford, England)] 19:295-296. doi: 10.1093/bioinformatics/19.2.295.
43. Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AK. 2011. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. The Journal of Experimental Medicine 208:479-490. doi: 10.1084/jem.20102131.
44. Perez-Losada J, Balmain A. 2003. Stem-cell hierarchy in skin cancer. Nature Reviews Cancer 3:434-443. doi: 10.1038/nrc1095.
45. Rice RH, Green H. 1977. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell 11:417-422. doi: 10.1016/0092-8674(77)90059-9.
46. Ruhrberg C, Hajibagheri MA, Parry DA, Watt FM. 1997. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. The Journal of Cell Biology 139:1835-1849. doi: 10.1083/jcb.139.7.1835.
47. Ruhrberg C, Hajibagheri MA, Simon M, Dooley TP, Watt FM. 1996. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. The Journal of Cell Biology 134:715-729. doi: 10.1083/jcb.134.3.715.
48. Sasaki T, Shiohama A, Kubo A, Kawasaki H, Ishida-Yamamoto A, Yamada T, Hachiya T, Shimizu A, Okano H, Kudoh J, Amagai M. 2013. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis. The Journal of Allergy and Clinical Immunology 132:1111-1120. doi: 10.1016/j.jaci.2013.08.027.
49. Saunders SP, Goh CS, Brown SJ, Palmer CN, Porter RM, Cole C, Campbell LE, Gierlinksi M, Barton GJ, Schneider G, Balmain A, Prescott AR, Weidinger S, Baurecht H, Kabeschm M, Giegerm C, Lee YA, Tavendale R, Mukhopadhyay S, Turner SW, Madhok VB, Sullivan FM, Relton C, Burn J, Meggitt S, Smith CH, Allen MA, Barker JN, Reynolds NJ, Cordell HJ, Irvine AD, McLean WH, Sandilands A, Fallon PG. 2013. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. The Journal of Allergy and Clinical Immunology 132:1121-1129. doi: 10.1016/j.jaci.2013.08.046.
50. Sevilla LM, Nachat R, Groot KR, Klement JF, Uitto J, Djian P, Maatta A, Watt FM. 2007. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. The Journal of Cell Biology 179:1599-1612. doi: 10.1083/jcb.200706187.
51. Sherman PW, Holland E, Sherman JS. 2008. Allergies: their role in cancer prevention. The Quarterly Review of Biology 83:339-362. doi: 10.1086/592850.
52. Simon M, Green H. 1984. Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 36:827-834. doi: 10.1016/0092-8674(84)90032-1.
53. Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M. 2008. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nature Immunology 9:146-154. doi: 10.1038/ni1556.
54. Swamy M, Jamora C, Havran W, Hayday A. 2010. Epithelial decision makers: in search of the 'epimmunome'. Nature Immunology 11:656-665. doi: 10.1038/ni.1905.
55. Thiery JP, Chopin D. 1999. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Reviews 18:31-42.
56. Teige I, Hvid H, Svensson L, Kvist PH, Kemp K. 2009. Regulatory T cells control VEGF-dependent skin inflammation. The Journal of Investigative Dermatology 129:1437-1445. doi: 10.1038/jid.2008.375.
57. Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N, Walldius G, Lambe M, Jungner I, Holmberg L. 2010. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes & Control: CCC 21:1657-1667. doi: 10.1007/s10552-010-9594-6.
58. Wedgeworth E, Powell AM, Flohr C. 2011. Eczema and cancer risk: a critical appraisal and review of the literature. The British Journal of Dermatology 165:457-462. doi: 10.1111/j.1365-2133.2011.10542.x.
59. Whang MI, Guerra N, Raulet DH. 2009. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin. The Journal of Immunology: official Journal of the American Association of Immunologists 182:4557-4564. doi: 10.4049/jimmunol.0802439.
60. Wiemels JL, Wiencke JK, Li Z, Ramos C, Nelson HH, Karagas MR. 2011. Risk of squamous cell carcinoma of the skin in relation to IgE: a nested case-control study. Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology 20:2377-2383. doi: 10.1158/1055-9965.EPI-11-0668.
61. Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH. 2004. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis 25:1771-1778. doi: 10.1093/carcin/bgh170.
62. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. The Journal of Experimental Medicine 202:541-549. doi: 10.1084/jem.20041503.
63. Zamarron BF, Chen W. 2011. Dual roles of immune cells and their factors in cancer development and progression. International Journal of Biological Sciences 7:651-658. doi: 10.7150/ijbs.7.651.
64. Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF. 2005. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nature Immunology 6:1047-1053. doi: 10.1038/ni1247.